Leaflet: Information for the user
balance1.5% glucose, 1.75 mmol/l calcium, solution for peritoneal dialysis
Read the entire leaflet carefully before starting to use this medicine, as it contains important information for you.
Contents of the leaflet:
balanceis used to clean the bloodvia the peritoneum in patients with chronic renal failure in the terminal phase. This type of blood cleaning is known as peritoneal dialysis.
Do not usebalance1.5% glucose, 1.75 mmol/l calcium
Peritoneal dialysis should not be started if you have:
Warnings and precautions
Inform your doctor immediately:
Peritoneal dialysis may cause loss of proteinsand water-soluble vitamins.
It is recommended to follow a suitable diet or take nutritional supplements to avoid deficiency states.
Your doctor should check the balance of electrolytes (salts), kidney function, body weight, and nutritional status.
Use ofbalancewith other medicines
Inform your doctor or pharmacist if you are using, have recently used, or may need to use any other medicine.
Peritoneal dialysis may alter the effect of some medicines, so your doctor may need to change the dose for some of them, especially the following:
Your doctor will check your blood potassium level and, if necessary, take appropriate measures.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor before using this medicine. There is no adequate data on the use of balancein pregnant or breastfeeding women. If you are pregnant or breastfeeding, you should use balanceonly if your doctor considers it absolutely necessary.
Driving and using machines
The influence of balanceon the ability to drive or use machines is negligible or non-existent.
Follow your doctor's instructions for administering this medicine exactly. If you are unsure, consult your doctor or pharmacist again.
Your doctor will determine the method, duration, and frequency of use, as well as the required volume of solution and the dwell time in the peritoneal cavity.
If you have tension in the abdominal region, your doctor may reduce the volume.
Continuous Ambulatory Peritoneal Dialysis (CAPD)
The solution is drained after a dwell time of between 2 and 10 hours.
The recommended initial dose is 600-800 ml/m2 of body surface area four times a day (up to 1000 ml/m2 at night).
Automated Peritoneal Dialysis (APD)
For this, the sleep•safeor Safe•Lock system is used. The bag exchange is controlled automatically by the cycler during the night.
Use balanceonly in the peritoneal cavity.
Use balanceonly if the solution is clear and the packaging is not damaged.
balanceis available in a double-chamber bag. Before using the solution in the two chambers, mix the solutions as described below.
Instructions for use:
Systemstay•safefor Continuous Ambulatory Peritoneal Dialysis (CAPD)
First, heat the bag with the solution to body temperature. This should be done using a suitable bag warmer. A 2000 ml bag at an initial temperature of 22°C will need about 120 minutes of warming time. You can obtain more detailed information in the manual of your warmer. To heat the solution, microwaves should not be used due to the risk of local overheating. The bag exchange can be carried out after warming the solution.
Check the bag with the tempered solution (label, expiration date, transparency of the solution, integrity of the bag and overbag, integrity of the weld). Place the bag on a solid surface. Open the overbag of the bag and the disinfection cap. Wash your hands using an antimicrobial washing solution. Roll up the bag, which is placed horizontally on the overbag, from one of the lateral edges until the intermediate weld opens. The solutions from the two chambers mix automatically. Now roll up the bag from the top edge until the lower triangle weld is completely open. Check that all welds are completely open. Check that the solution is clear and that the bag has no leaks.
Hang the bag with the solution on the upper hanger of the infusion stand, unroll the tubes of the bag with the solution, and place the DISC connector in the organizer. After unrolling the tubes of the drainage bag, hang the bag on the lower hanger of the infusion stand. Place the catheter connector in one of the two connections of the organizer. Put the new disinfection cap on the remaining free connection. Disinfect your hands and remove the protective cap from the DISC connector. Connect the catheter connector to the DISC connector.
Open the extension valve. The outflow starts.
Position ?
Once the outflow is complete, purge the drainage bag with new liquid (approximately 5 seconds).
Position ??
Start the inflow by turning the rotary switch to the
Position ???
Close the catheter extension by inserting the PIN into the catheter connector.
Position ????
Remove the protective cap from the new disinfection cap and screw it onto the old one. Unscrew the catheter connector from the DISC connector and screw it onto the new disinfection cap.
Close the DISC connector with the open end of the used disinfection cap, which is placed in the right hole of the organizer.
Systemsleep•safefor Automated Peritoneal Dialysis (APD)
During automated peritoneal dialysis (APD), the cycler heats the solution automatically.
Systemsleep•safeof 3000 ml
Systemsleep•safeof 5000 and 6000 ml
Check the bag with the solution (label, expiration date, transparency of the solution, integrity of the bag and overbag, integrity of the weld). Place the bag on a solid surface. Open the overbag of the bag. Wash your hands using an antimicrobial washing solution. Unfold the intermediate weld and the bag connector. Roll up the bag, which is placed horizontally on the overbag, from the diagonal end towards the bag connector. The intermediate weld will open. Continue until the weld of the small chamber also opens. Check that all welds are completely open. Check that the solution is clear and that the bag has no leaks.
SystemSafe•Lockfor Automated Peritoneal Dialysis (APD)
During automated peritoneal dialysis (APD), the cycler heats the solution automatically.
The bags are for single use, and any unused solution should be discarded.
After proper training, balancecan be used independently at home. Make sure to follow all the steps you have learned during training and maintain adequate hygiene conditions when exchanging bags.
Always check the turbidity of the drained dialysate. See section 2.
If you use morebalancethan you should
If you infuse an excess of dialysis solution into the peritoneal cavity, it can be drained. If you use too many bags, contact your doctor, as it may cause electrolyte and/or fluid imbalance.
In case of overdose or accidental ingestion, consult your doctor or pharmacist or call the Toxicology Information Service, phone 91 562 04 20, indicating the medicine and the amount ingested.
If you forget to usebalance
Try to reach the total prescribed volume for each 24-hour period to avoid consequences that may put your life at risk. You should consult your doctor if you have doubts.
If you have any other questions about the use of this medicine, ask your doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
You may experience the following side effects as a result of peritoneal dialysis treatment in general:
very common (may affect more than 1 in 10 people)
Show your doctor the bag containing the drainage solution.
Contact your doctor immediately if you experience any of these side effects.
Other side effects of the treatment are the following:
common (may affect up to 1 in 10 people)
uncommon (may affect up to 1 in 100 people)
very rare(may affect up to 1 in 10,000 people)
not known(frequency cannot be estimated from the available data)
You may experience the following side effects when using balance:
very common(may affect more than 1 in 10 people)
common (may affect up to 1 in 10 people)
uncommon (may affect up to 1 in 100 people)
Reporting of side effects
If you experience any side effects, consult your doctor, pharmacist, or nurse, even if they are not listed in this leaflet. You can also report them directly through the Spanish Medicines Monitoring System for Human Use: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date stated on the bag and carton after EXP. The expiration date is the last day of the month indicated.
Do not store at a temperature below 4°C.
The ready-to-use solution should be used immediately, within 24 hours after mixing.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.
Composition ofbalance
Calcium chloride dihydrate 0.2573 g
Sodium chloride 5.640 g
Sodium (S)-lactate solution 7.85 g
(3.925 g sodium (S)-lactate)
Magnesium chloride hexahydrate 0.1017 g
Glucose monohydrate 16.5 g
(15.0 g anhydrous glucose)
These amounts of active substance are equivalent to:
1.75 mmol/l calcium, 134 mmol/l sodium, 0.5 mmol/l magnesium, 101.5 mmol/l chloride, 35 mmol/l lactate, and 83.2 mmol/l glucose.
The other components are water for injectable preparations, hydrochloric acid, sodium hydroxide, and sodium bicarbonate.
Appearance of the Product and Container Content
The solution is transparent and colorless.
The theoretical osmolarity of the ready-to-use solution is 358 mOsm/l, and the pH is approximately 7.0.
balanceis available in double-chamber bags. One chamber contains the alkaline sodium lactate solution, and the other chamber contains the acidic glucose solution with electrolytes.
balanceis available in the following application systems and container sizes:
stay•safe: 4 bags of 2000 ml 4 bags of 2500 ml 4 bags of 3000 ml | sleep•safe: 4 bags of 3000 ml 2 bags of 5000 ml 2 bags of 6000 ml | Safe•Lock: 2 bags of 5000 ml 2 bags of 6000 ml |
Only some container sizes may be marketed.
Marketing Authorization Holder:
Fresenius Medical Care Deutschland GmbH, Else-Kröner-Straße 1, 61352 Bad Homburg v.d.H. Germany
Manufacturer:
Fresenius Medical Care Deutschland GmbH, Frankfurter Straße 6-8, 66606 St. Wendel Germany
Local Representative:
Fresenius Medical Care España S.A.
C/ Ronda de Poniente, 8, ground floor, Parque Empresarial Euronova,
28760 Tres Cantos (Madrid)
Spain
This medicinal product is authorized in the Member States of the European Economic Area under the following names:
See the end of this multilingual prospectus.
Date of the last revision of this prospectus: 01/2020
Detailed and updated information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/.